Iconic Labs : New Consulting and Marketing Agreement Signed

RNS Number : 5144Z

Iconic Labs PLC

13 January 2020

13 January 2020

Iconic Labs Plc ("Iconic Labs" or the "Company")

New Consulting and Marketing Agreement Signed

Iconic Labs Plc (LSE:ICON), a multi-divisional new media and technology business, is pleased to announce that it has signed a consulting and marketing services agreement ('the Agreement') with a UK based online wellness platform.

Under the terms of the Agreement, Iconic will deliver an initial six week campaign with the client having an option to extend it to 12 months. Work commences immediately and Iconic will be consulting with the client to create and distribute advertising content aimed at the 'on-demand Yoga and Pilates' market, which is worth over £800m in the UK alone. For commercial reasons, the value of this Agreement has not been disclosed.

Iconic Chief Executive Officer, John Quinlan, said, "We are delighted to secure this contract with a disruptive client in such a large and growing market; we hope this will be the start of a long and strategic partnership. Securing new contracts is a lengthy process; our pipeline in this regard is growing and we anticipate signing further similar agreements soon. This is a positive start to the year, and I look forward to regularly updating investors on our progress."

**ENDS**

For further information, please visit the Company's website www.iconiclabs.co.ukor contact:

John Quinlan	Iconic Labs Plc		c/o SBP Tel: [phone]
				1177
Damon Heath	Shard	Capital	Partners	Tel: [phone]
	LLP
Simon Leathers	Shard	Capital	Partners	Tel: [phone]
	LLP
Isabel de Salis	St	Brides	Partners	Tel: [phone]
	Limited
David Penson	St	Brides	Partners	Tel: [phone]
	Limited

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please [e-mail] visit www.rns.com.

END

AGRUUSBRRVUAAAR

Page 1 of 1